Source: GlobeNewswire

Press Release: Verastem : INVESTOR ALERT: Fields Kupka & Shukurov LLP Is Investigating Verastem, Inc. for Potential Breach of Fiduciary Duty Claims.

NEW YORK, April 09, 2020 (GLOBE NEWSWIRE) -- Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Verastem, Inc. (NASDAQ: VSTM).

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Brian Stuglik's photo - CEO of Verastem

CEO

Brian Stuglik

CEO Approval Rating

66/100

Verastem is a biopharmaceutical company that researches, develops and commercializes novel therapeutics for the treatment of cancer. Read more